ProCE Banner Activity

How I Manage Treatment Challenges in MDS

Clinical Thought
Rami S. Komrokji, MD, discusses the challenges of diagnosing and treating patients with MDS and the promising treatments in phase III trials.

Released: November 20, 2020

Expiration: November 19, 2021

Share

Faculty

Rami S. Komrokji

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Taiho Oncology Inc

Faculty Disclosure

Primary Author

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Rami S. Komrokji, MD, has disclosed that he has received consulting fees from Acceleron, AbbVie, Agios, Bristol-Myers Squibb, Celgene, Geron, Incyte, Jazz, Novartis, and Pfizer.